Now showing items 1-6 of 6
Anti-cholinergic load, health care utilization, and survival in people with advanced cancer: a pilot study
(Mary Ann Liebert, Inc., 2010-07-02)
Introduction: Anti-cholinergic medications have been associated with increased risks of cognitive impairment, premature mortality and increased risk of hospitalisation. Anti-cholinergic load associated with medication ...
Adverse events in hospice and palliative care: a pilot study to determine feasibility of collection and baseline rates
(Mary Ann Liebert, Inc., 2011-01-19)
Background: Continuous quality improvement is fundamental in all health care, including hospice and palliative care. Identifying and systematically reducing symptomatic adverse events is limited in hospice and palliative ...
Core medicines for quality care of the dying
(Mary Ann Liebert, Inc., 2013-05-16)
The proposal by Lindqvist and colleagues of four essential medicines for the control of terminal symptoms is commendable. Having a finite essential medication list facilitates prescribers to prescribe and pharmacies to ...
An international initiative to create a collaborative for pharmacovigilance in hospice and palliative care clinical practice
(Mary Ann Liebert, Inc., 2012-02-21)
Background: Medication registration currently requires evidence of safety and efficacy from adequately powered phase 3 studies. Pharmacovigilance (phase 4 studies, postmarketing data, adverse drug reaction reporting) provide ...
The role of ondansetron in the management of cholestatic or uremic pruritis - a systematic review
Pruritus associated with hepatic or renal failure can be a troublesome symptom, refractory to treatment, associated with significant physical and emotional distress, and reduction in quality of life for patients already ...
Off-label prescribing in palliative care – a cross-sectional national survey of Palliative Medicine doctors
(SAGE Publications, 2012-11-05)
Background: Regulatory bodies including the European Medicines Agency register medications (formulation, route of administration) for specific clinical indications. Once registered, prescription is at clinicians’ discretion. ...